SEOUL, Mar. 21 (Korea Bizwire) — Global pharmaceutical company Merck Life Science said Thursday it will invest some 430 billion won (US$324 million) to build a new bioprocessing production facility in South Korea. The European bio firm plans to build a 43,000 square-meter center in Daejeon, about 140 kilometers south of Seoul, equipped with production, [...]
SEATTLE, Oct. 17 (Korea Bizwire) — Kineta, Inc. (“Kineta” or the “Company”), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology, announced today that it has entered into a clinical trial collaboration and supply agreement with Merck (known as MSD outside the U.S. and Canada). Under this collaboration, Kineta will evaluate [...]
SEOUL, Jan. 20 (Korea Bizwire) — Three South Korean companies are among 27 drugmakers chosen to produce low-cost versions of Merck & Co.’s COVID-19 pill for low- and-middle-income countries, the Medicines Patent Pool (MPP) and Seoul’s health ministry said Thursday. The U.N.-backed public health organization announced that it signed sublicense agreements with 27 generic drug [...]
SEOUL, Oct. 8 (Korea Bizwire) — Germany-based technology firm Merck Group said Friday it plans to invest around US$693 million in South Korea through 2025 in the electronics sector, including semiconductor solutions. The investment by Merck is expected to lend hands to South Korea’s so-called K-semiconductor blueprint, and help the country secure a stable supply [...]
RALEIGH, N.C. , April 7 (Korea Bizwire) — PRA Health Sciences (NASDAQ: PRAH) announced today that Merck KGaA, Darmstadt, Germany, known in the United States as EMD Serono, selected PRA’s remote patient monitoring platform to work in combination with its human growth hormone (HGH) treatment system. Under this agreement, PRA’s remote patient monitoring platform backs [...]
Amsterdam, the Netherlands, Jan. 14 (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a multi-year partnership with Merck, a leading science and technology company, to develop clinical-grade digital solutions for highly personalized fertility treatment. Leveraging digital health technologies, advanced informatics and mobile, AI-enabled ultrasound diagnostics, these solutions will [...]
SEOUL, Aug. 4 (Korea Bizwire) — Hanmi Pharmaceutical said Tuesday that it has exported technology for a liver treatment drug material to leading global drugmaker Merck Sharp & Dohme (MSD). The deal is for the efinopegdutide (HM12525A) candidate material that has potential to be used on people with nonalcoholic steatohepatitis (NASH) conditions, a kind of [...]
SEOUL, Dec. 1 (Korea Bizwire) – To maintain its status as the world’s largest biopharmaceuticals manufacturing city, voices in Songdo are calling for greater cooperation between the private and public sectors. Leading biopharmaceuticals firms, among them Samsung Biologics and Celltrion, have made large investments in Songdo to build up the city’s manufacturing capabilities. By next [...]
NEW DELHI, India, Nov. 3 (Korea Bizwire) — Merck (http://www.MerckGroup.com), a leading science and technology company, through “Merck More than a Mother” (www.MerckMoreThanaMother.com) in partnership with the International Federation of Fertility Societies (IFFS) conducted a panel to address infertility challenges and solutions in Africa at the IFFS World Congress in New Delhi, India. The ministers, [...]
INCHEON, Oct. 4 (Korea Bizwire) – The Songdo International Business District is quickly establishing itself as a new hub for the biotech industry, already housing major pharmaceutical and healthcare enterprises like Samsung BioLogics and CellTrion, and attracting further investment from global firms. According to industry watchers, GE Healthcare and Merck Group will open new training [...]